Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP8 | Q6V1X1 | 9/20 | 0.61 |
| ▸ | DPP9 | Q86TI2 | 9/20 | 0.61 |
| ▸ | DPP4 | P27487 | 6/20 | 0.61 |
| ▸ | BLM | P54132 | 2/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.38 |
| ▸ | DPP7 | Q9UHL4 | 8/20 | 0.35 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.34 |
| ▸ | BMP1 | P13497 | 1/20 | 0.31 |
| ▸ | CTSD | P07339 | 1/20 | 0.31 |
| ▸ | BACE1 | P56817 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7947817 | 1.00 | DPP8 (0.61) | DPP8DPP9DPP4BLMALOX15 | |
| SCHEMBL7762244 | 0.82 | DPP8 (0.69) | DPP8DPP9DPP4BLMALOX15 | |
| SCHEMBL10940865 | 0.82 | DPP8 (0.69) | DPP8DPP9DPP4BLMALOX15 | |
| SCHEMBL17347919 | 0.81 | DPP4 (0.55) | DPP8DPP9DPP4BLMALOX15 | |
| SCHEMBL5579743 | 0.79 | DPP4 (0.39) | DPP8DPP9DPP4BLMALOX15 | |
| SCHEMBL30799779 | 0.79 | DPP8 (0.65) | DPP8DPP9DPP4BLMALOX15 | |
| SCHEMBL8560140 | 0.78 | PAX8 (0.45) | DPP8DPP9DPP4SLC15A1DPP7 | |
| SCHEMBL10067240 | 0.78 | DPP9 (0.44) | DPP8DPP9DPP4SLC15A1DPP7 | |
| SCHEMBL2739683 | 0.78 | DPP9 (0.44) | DPP8DPP9DPP4SLC15A1DPP7 | |
| SCHEMBL2739682 | 0.78 | DPP9 (0.44) | DPP8DPP9DPP4SLC15A1DPP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2001054729-A1 | TREATMENT OF NEUROPSYCHIATRIC DISEASE WITH PROTEASE AND NEURAMINIDASE INHIBITORS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, ASREPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2001-08-02 | — | — | WO | disclosed |